The global market for inhalation and nasal spray generic drugs is on a steady upward trajectory, driven by the rising global burden of respiratory disease and an aging population that increasingly relies on affordable, accessible respiratory therapies. As branded inhalers and nasal sprays face patent expirations, generic alternatives are stepping in to fill the gap — offering comparable...